{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-002396","form_type":"8-K","ticker":"NXTC","cik":"0001661059","company_name":"NextCure, Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.350758+00:00","generated_at":"2026-05-25T06:20:14.578161+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NextCure reports FY2024 net loss of $55.7M; cash $68.6M, LNCB74 Phase 1 advancing","bullets":["Net loss of $55.7M in FY2024 improved from $62.7M in FY2023; R&D expenses $41.5M, G&A $15.7M, both down YoY.","Cash, equivalents, and marketable securities $68.6M at Dec 31, 2024 (vs $108.3M); expected to fund operations into H2 2026.","LNCB74 (B7-H4 ADC) Phase 1: completed cohort 1 in Feb 2025, currently dosing cohort 2; backfill cohorts planned H2 2025.","Preclinical non-oncology programs (NC181 for Alzheimer's, NC605 for osteogenesis imperfecta) seeking partnerships.","Potential IND filings for NC181 and NC605 within 12-18 months if partner or third-party funding secured."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-002396","json":"https://secwatch.observer/filing/0001558370-25-002396.json","markdown":"https://secwatch.observer/filing/0001558370-25-002396.md","text":"https://secwatch.observer/filing/0001558370-25-002396.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025002396/0001558370-25-002396-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1661059/000155837025002396/nxtc-20250306x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T06:20:14.578161+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}